The quality of pharmacologic care for adults in the United States. Medical Care , 44:936–945,
Off-label prescribing among office-based physicians. Archives of Internal Medicine 166:1021–1026,
The quality of antipsychotic drug prescribing in nursing homes. Archives of Internal Medicine 165:1280–1285,
Inappropriate medication prescribing for elderly ambulatory care patients. Archives of Internal Medicine 164:305–312,
Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study. American Journal of Managed Care 10:742–750,
Overuse of proton pump inhibitors. Journal of Clinical Pharmacy and Therapeutics , 25:333–340,
Measuring antidepressant prescribing practice in a health care system using administrative data: implications for quality measurement and improvement. Joint Commission Journal on Quality and Safety 26:203–216,
Overuse of antidepressant drugs for the treatment of depression. CNS Drugs 20:623–632,
Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists: the Tortoise and the Hare revisited. Journal of General Internal Medicine 21:694–697,
The urgent need to improve health care quality: Institute of Medicine National Roundtable on Health Care Quality. JAMA 280:1000–1005,
Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication. Archives of General Psychiatry 64:1196–1203,
Office of the Actuary: Estimated Financial Effects of the “Patient Protection and Affordable Care Act,” as Amended .
Centers for Medicare and Medicaid Services,
Prescribing trends in psychotropic medication. JAMA 279:526–531,
National patterns in antidepressant medication treatment. Archives of General Psychiatry 66:848–856,
Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications. Journal of the American Medical Directors Association , 11:320–324,
Efficacy of antidepressants in adults. British Medical Journal 331:155–157,
The emperor's new drugs: an analysis of antidepressant medication submitted to the US Food and Drug Administration. Prevention and Treatment 5:article 23,
Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence. Drug Safety 26:5–64,
Treatment of Depression—Newer Pharmacotherapies: Evidence Report/Technology Assessment . No 7.
Agency for Health Care Policy and Research,
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 297:1683–1696,
The relationship between antidepressant medication use and rate of suicide. Archives of General Psychiatry 62:165–172,
Prevalence and treatment of mental disorders, 1990 to 2003. New England Journal of Medicine 352:2515–2523,
Recognition of mental distress and diagnosis of mental disorders in primary care. JAMA 253:1903–1907,
Depression in medical outpatients: under-recognition and misdiagnosis. Archives of Internal Medicine 150:1083–1088,
S: Unmet Need in Psychiatry: Problems, Resources, Responses .
Cambridge University Press,
Antidepressant use and use patterns in naturalistic settings. Drug Benefit Trends 6:7–12,
The de facto US mental and addictive disorders service system: epidemiological catchment area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry 50:85–94,
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry 51:8–19,
Assessing population need for mental health care: a review of approaches and predictors. Mental Health Services Research 6:33–46,
What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters. International Journal of Psychiatry in Medicine 28:407–419,
Sociological influences on antidepressant prescribing. Social Science and Medicine 56:1335–1344,
Stata Statistical Software: Release 9 .
College Station, Tex,
Design and Methods of the Medical Expenditure Panel Survey Household Component. MEPS Methodology Report No 1 . AHCPR publication 97-0026.
Agency for Healthcare Research and Quality,
Sensitivity of household reported medical conditions in the Medical Expenditure Panel Survey. Medical Care 47:618–625,
International Classification of Diseases, Ninth Revision, Clinical Modification .
Public Health Service, US Dept of Health and Human Services,
Physicians' Desk Reference , 60th ed.
Medical Economics Co,
Racial and ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiology and Drug Safety 19:834–842,
United States Pharmacopeia: National Formulary, online version 2002, 2003, 2004, 2005, 2006 .
US PharmacopeiaAvailable at www.usp.org/USPNF
July 30, 2009
Payment for covered outpatient drugs and biologicals. Federal Register 69:55763,
DRUGDEX System, CD-ROM, version 5.1. Thomson Micromedex.
A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Archives of Internal Medicine 156:1047–1052,
SD: SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales , 2nd ed.
New England Medical Center, Health Institute,
Validity of the mental health component scale of the 12-Item Short-Form Health Survey (MCS-12) as measure of common mental disorders in the general population. Psychiatry Research 152:63–71,
S: Applied Logistic Regression .
The deliberate misdiagnosis of major depression in primary care. Archives of Family Medicine 3:333–337,